Search research articles
Contact Us
Filters
Showing results (71-80 of 142) with videos related to
Page
of 15
Sort By:
Gynecologic Oncology
|
December 14, 2011
Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma
R A de Jong, N L Toppen, K A Ten Hoor, et al.
Gynecologic Oncology
|
July 21, 2004
Pitfalls in the sentinel lymph node procedure in vulvar cancer
J A de Hullu, M H M Oonk, A C Ansink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 17, 1999
The importance of family history in young patients with endometrial cancer
M J Berends, J H Kleibeuker, E G de Vries, et al.
International Journal of Cancer
|
June 17, 1999
Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis
H J Arts, H Hollema, W Lemstra, et al.
British Journal of Cancer
|
March 10, 1999
DNA topoisomerase IIalpha and -beta expression in human ovarian cancer
S Withoff, A G van der Zee, S de Jong, et al.
Annals of Surgical Oncology
|
June 19, 2014
Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer
L M A Schreurs, J K Smit, K Pavlov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 24, 2017
The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment
M A C Versluis, S Marchal, A Plat, et al.
Gynecologic Oncology
|
February 27, 2004
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma
H J G Arts, S de Jong, H Hollema, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates
M Jalving, J J Koornstra, W Boersma-van Ek, et al.
Cancer Research
|
November 1, 1991
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy
A G van der Zee, H Hollema, S de Jong, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 142) with videos related to
Sort By:
Page
of 15
Gynecologic Oncology
|
December 14, 2011
Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma
R A de Jong, N L Toppen, K A Ten Hoor, et al.
Gynecologic Oncology
|
July 21, 2004
Pitfalls in the sentinel lymph node procedure in vulvar cancer
J A de Hullu, M H M Oonk, A C Ansink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 17, 1999
The importance of family history in young patients with endometrial cancer
M J Berends, J H Kleibeuker, E G de Vries, et al.
International Journal of Cancer
|
June 17, 1999
Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis
H J Arts, H Hollema, W Lemstra, et al.
British Journal of Cancer
|
March 10, 1999
DNA topoisomerase IIalpha and -beta expression in human ovarian cancer
S Withoff, A G van der Zee, S de Jong, et al.
Annals of Surgical Oncology
|
June 19, 2014
Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer
L M A Schreurs, J K Smit, K Pavlov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 24, 2017
The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment
M A C Versluis, S Marchal, A Plat, et al.
Gynecologic Oncology
|
February 27, 2004
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma
H J G Arts, S de Jong, H Hollema, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates
M Jalving, J J Koornstra, W Boersma-van Ek, et al.
Cancer Research
|
November 1, 1991
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy
A G van der Zee, H Hollema, S de Jong, et al.
Page
of 15